CompletedNot Applicable

Ectoin® Lozenges in the Treatment of Acute Viral Pharyngitis

Germany90 participantsStarted 2016-01

Plain-language summary

This a comparative, open label, parallel group, non interventional study which compares the tolerability and influence of Ectoin containing Lozenges to saline solution and lozenges containing hyaluronic acid for the treatment of acute viral Pharyngitis. The observation takes place over a period of 7 days. Response to treatment is recorded at day 1 and day 7 by the physician and by the patient in a dairy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with acute Pharyngitis according to instruction for use * Female or male individuals ≥ 18 years * Agreement to abide by the routinely provided doctor's appointment for follow- up (reflected in the planned visits of observation plan resist) Exclusion Criteria: * Contraindications according to instructions for use * Male or female person under 18 years * Sore throat for more than 5 days * Any disease that can, in the opinion of the treating physician to affect the outcome of the study. * Patients with known intolerance to one of the substances used * Surgical procedures to the mouth and throat in the last 6 weeks before inclusion in the NIS * Bacterial Pharyngitis * Pregnancy

What they're measuring

Change in Pharyngitis symptom score evaluated by the physician

Timeframe: day 1 and day 7

Trial details

NCT IDNCT02669446

SponsorBitop AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2016-05

View on ClinicalTrials.gov More Acute Viral Pharyngitis trials